Tandem peptides targeting HER2 for delivery of CD44 siRNA into HER2+breast cancer cells in vitro

被引：0
|
作者：
Kalogeros, James W.
Miserendino, Audreanna
Alexander-Bryant, Angela
Booth, Brian
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
基金：
美国国家科学基金会;
关键词：
D O I：
10.1158/1538-7445.AM2023-3979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3979
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting EGFR & HER2 & HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Antitumor Activity in HER2 Expressing Breast Cancer
    Liu, Hong Yan
    MOLECULAR THERAPY, 2018, 26 (05) : 147 - 147
  • [42] A phase I study of a DNA plasmid based vaccine encoding the HER2/neu (HER2) intracellular domain (ICD) in subjects with HER2+breast cancer
    Salazar, L. G.
    Slota, M.
    Wallace, D.
    Higgins, D.
    Coveler, A. L.
    Dang, Y.
    Childs, J.
    Bates, N.
    Waisman, J.
    Disis, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Molecular targeting of HER2 for diagnosis and therapy of breast cancer
    Capala, J.
    Kramer-Marek, G.
    Lee, S. B.
    Hassan, M.
    Kiesewetter, D. O.
    Puri, A.
    Chernomordik, V
    Gandjbakhche, A.
    Griffiths, G.
    Blumenthal, R.
    CANCER RESEARCH, 2009, 69 (02) : 349S - 349S
  • [44] Targeting HER2 in brain metastases from breast cancer
    Kirsch, DG
    Hochberg, FH
    CLINICAL CANCER RESEARCH, 2003, 9 (15) : 5435 - 5436
  • [45] Simultaneous targeting of estrogen receptor and HER2 in breast cancer
    Azim, Hatem A., Jr.
    Piccart, Martine J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (08) : 1255 - 1263
  • [46] Targeting HER2 Positive Breast Cancer with Chemopreventive Agents
    Wahler J.
    Suh N.
    Current Pharmacology Reports, 2015, 1 (5) : 324 - 335
  • [47] HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
    Geng, Lingling
    Wang, Zihua
    Jia, Xiangqian
    Han, Qiuju
    Xiang, Zhichu
    Li, Dan
    Yang, Xiaoliang
    Zhang, Di
    Bu, Xiangli
    Wang, Weizhi
    Hu, Zhiyuan
    Fang, Qiaojun
    THERANOSTICS, 2016, 6 (08): : 1261 - 1273
  • [48] Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+Breast Cancer Subtypes
    Watson, Spencer S.
    Dane, Mark
    Chin, Koei
    Tatarova, Zuzana
    Liu, Moqing
    Liby, Tiera
    Thompson, Wallace
    Smith, Rebecca
    Nederlof, Michel
    Bucher, Elmar
    Kilburn, David
    Whitman, Matthew
    Sudar, Damir
    Mills, Gordon B.
    Heiser, Laura M.
    Jonas, Oliver
    Gray, Joe W.
    Korkola, James E.
    CELL SYSTEMS, 2018, 6 (03) : 329 - +
  • [49] Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
    Adam-Artigues, Anna
    Arenas, Enrique J.
    Martinez-Sabadell, Alex
    Braso-Maristany, Fara
    Cervera, Raimundo
    Tormo, Eduardo
    Hernando, Cristina
    Teresa Martinez, Maria
    Carbonell-Asins, Juan
    Simon, Soraya
    Poveda, Jesus
    Moragon, Santiago
    Zazo, Sandra
    Martinez, Debora
    Rovira, Ana
    Burgues, Octavio
    Rojo, Federico
    Albanell, Joan
    Bermejo, Begona
    Lluch, Ana
    Prat, Aleix
    Arribas, Joaquin
    Eroles, Pilar
    Miguel Cejalvo, Juan
    SCIENCE ADVANCES, 2022, 8 (20):
  • [50] Cancer Vaccines Targeting HER2/neu for Early Breast Cancer
    Ryu, Woo Sang
    Son, Gil Soo
    JOURNAL OF BREAST CANCER, 2010, 13 (01) : 5 - 13
12345